SOD1 and amyotrophic lateral sclerosis: In ALS, numerous studies are focusing on the use of small molecules as drug-like agents, from molecules capable of decreasing SOD1 expression levels [31,32] to those that would stabilize SOD1 and prevent its aggregation [33].